Thompson Cancer Survival Center

What it reported doing in 2024

At Thompson Cancer Survival Center, leading cancer specialists use the most advanced technologies to achieve breakthrough successes in treating many types of cancer. Our network of cancer care providers, including those in Thompson Oncology Group (our own medical oncology, hematology, and gynecologic oncology practice), is supported by a team of patient navigators, oncology pharmacists, dietitians, genetics counselors, clinical trial specialists, physicists, therapists, technologists, oncology nurses, social workers, and counselors, all working to treat and beat cancer. In addition to innovative technologies and treatment methodologies, Covenant Health added a new proton therapy center to the treatment options at Thompson Cancer Survival Center. Patients can now receive proton therapy as part of Covenant Health's umbrella of cancer services offered at Thompson Cancer Survival Center locations throughout the region and the Covenant Cancer Network. One of only 45 proton therapy facilities in the United States, Thompson Proton Center offers an advanced form of radiation therapy that uses beams of high-energy protons to treat various forms of cancer, while protecting nearby healthy tissue and vital organs from unnecessary radiation. Thompson Proton Center treated 345 patients in 2024. SERVICEThompson Cancer Survival Center ("TCSC") offers a range of cancer support services with the aim of providing patients receiving cancer treatment the best possible outcome for their individual situations. Support services include cancer outreach services, treatment care coordination and oncology clinical trials.Covenant Health facilities identify and refer patients to the TCSC Social Services department. In 2024, there were 2,118 new patient referrals to Social Services and 6,254 follow-up patients. The Social Services department includes a nutritional counseling and education program and a genetics clinic. The nutritional counseling and education program had 2,763 new patient referrals in 2024 with 4,019 follow-up assessments and 3,254 education encounters to support patients. In 2024, the genetics clinic received referrals for 1,098 new patients who were in need of genetic counseling. Of these patients, 748 were scheduled, 522 completed genetic counseling, and 412 elected to pursue genetic testing. All patients were able to receive full personal and family history reviews, allowing for a thorough risk assessment for the potential of a hereditary cancer syndrome or other familial risk factors possibly not accounted for through genetic testing. The patients received education and counseling regarding their pursuit of genetic testing. When appropriate, patients received information about support resources for individuals in similar circumstances. Finally, all patients received recommendations for risk-reduction strategies personalized for their individual health history, family history, and genetic test results when available. A goal of TCSC is to provide treatment care coordination for each patient. This goal is achieved by two means: the Multidisciplinary Treatment program and the Nurse Navigator program.Multidisciplinary Treatment is a process of individual patient consultation with members of the patient's oncology care team, where treatment options are discussed based on that individual's circumstances. This approach gives the physician the opportunity to relate one-on-one with the oncology patient and explain treatment choices in layperson's language. Patients needing care coordination come from various Covenant Health organizations and other facilities. The program currently consists of 14 nurses, one department assistant and one conference and patient housing coordinator to support oncology patients throughout the Covenant health system.The TCSC Nurse Navigator program was developed to help oncology patients overcome multiple barriers to healthcare, depending on their needs. Common barriers include financial, education, transportation, l

Financial Efficiency

• Mission deployment rate: 100%; rating input score 100
• Program expense ratio: 89%; rating input score 89
• Fundraising efficiency: Limited

Transparency & Controls

• Consistency checks: 92.3%; rating input score 92; 10th percentile among comparable filings
• Pay-setting controls: 0 of 6 controls in place; rating input score 0
  • Compensation committee: Missing
  • Independent consultant: Missing
  • Other Form 990s reviewed: Missing
  • Written employment contract: Missing
  • Compensation survey or study: Missing
  • Board or committee approval: Missing
• Foreign activity oversight: Limited
• Grant itemization coverage: 98.6%; rating input score 99; 35th percentile among comparable filings
• Major donor itemization: Yes; rating input score 100
• Related-party transparency: Yes; rating input score 100

Accountability

• Independent voting board: 95%; rating input score 95; 25th percentile among comparable filings
• Governance controls: 9 of 9 controls in place; rating input score 100
  • Conflict-of-interest policy: Pass
  • Whistleblower policy: Pass
  • Document-retention policy: Pass
  • CEO compensation review process: Pass
  • Other executive compensation review process: Pass
  • Form 990 shared with the board: Pass
  • Board meeting minutes documented: Pass
  • Audit committee oversight: Pass
  • Independent financial-statement audit: Pass

Sustainability

• Operating margin: -70.7%; rating input score 1; 1st percentile among comparable filings
• Total-asset coverage ratio: 4.24; rating input score 81; 81st percentile among comparable filings
• Liabilities to assets ratio: 0.03; rating input score 75; 75th percentile among comparable filings
• Officer compensation ratio: 14.3%; rating input score 20; 20th percentile among comparable filings

Growth

• Program expense growth: 0.9% per year; rating input score 100; 17th percentile among comparable filings
• Revenue growth: -7% per year; rating input score 0; 2nd percentile among comparable filings
• Asset growth: 1.2% per year; rating input score 100; 16th percentile among comparable filings